A 77-yr-old man undergoing insertion of a J-splint for renal obstruction received general anesthesia delivered with an ADU anesthesia machine (Anesthesia Delivery Unit; Datex-Ohmeda, Stockholm, Sweden). A 5% desflurane vaporizer concentration setting with an O 2 /N 2 O mixture (2 and 3 l/min, respectively) resulted in stable inspired and expired desflurane concentrations ( fig. 1 ). Immediately after lowering the fresh gas flow (FGF) to 0.35 l/min O 2 and 0.35 l/min N 2 O, and while maintaining the same vaporizer concentration setting, a dramatic increase in inspired and expired desflurane concentrations to about 14% (15:45) was noticed, as shown in figure 1 . The duration of this high concentration was short-lived (Ͻ 2 min) and did not trigger an alarm; the vaporizer concentration setting was decreased to 4.5% and was left unchanged throughout the remainder of the procedure (until 16:13). After a rapid decrease of the inspiratory and end-expiratory desflurane concentrations to about 7-8.5%, the concentrations started to increase again, leading to a gradual decrease in blood pressure. Because vaporizer malfunction was suspected, the FGF was increased to 5 l/min O 2 /N 2 O and was decreased again (to the previous settings) within a period of 1 min (15:56). Inspired and expired concentrations were noticed to decrease and increase again. This maneuver was repeated at 16:03, confirming that indeed something was wrong with the vaporizer output with the use of lower FGF (0.7 l/min). At 16:05, the FGF was therefore increased to 5 l/min. Vaporizer output itself was then checked at low FGF (0.7 l/min) by interrupting ventilation and having the sampling line of the multigas analyzer (Compact Airway Module M-CAiOV, Datex-Ohmeda, Helsinki, Finland) sample gases leaving the common gas outlet (16:10). Desflurane output read 14.5% (at 16:10) during the use of low flows, but matched the dialed 4.5% (16:12) when the FGF was increased again to its previous settings (O 2 /N 2 O mixture, 2 and 3 l/min, respectively). An alarm message appeared ("Service fresh gas unit."). Anesthesia was continued for a few more minutes for the remainder of the surgical procedure with desflurane and high FGF (5 l/min), and the patient was allowed to awaken without further incident.
Vaporizer output increased with lower FGF, with the largest error with FGF of 0.2 l/min (4.3 and 7.3% absolute output measured with 3% and 6% dialed, respectively, in a single instance). In the current case, however, substantially higher total FGFs (0.7 l/min) were used. Very preliminary testing by Datex-Ohmeda indicates that the one-way valve that prevents backflow of saturated vapor from the cassette via inspiratory channel toward the bypass channel may have failed to close after lowering the FGF ( fig. 2) . 2 This problem may be more significant when desflurane is used because the pressure in the desflurane Aladin cassette (Datex-Ohmeda, Stockholm, Sweden) may exceed 1 atm because of its high vapor pressure when the temperature is greater than 22.8°C (boiling point of desflurane at 1 atm pressure). A similar problem in 1999 prompted a redesign of this one-way valve and an upgrading of all ADU anesthesia machines in service worldwide (Mr. Ola Lassborn, Quality Manager, Datex-Ohmeda, Stockholm, Sweden, verbal personal communication, March 2003) . Despite the new design, this report suggests a continued problem with this valve with the possible delivery of unintended high concentrations of inhaled anesthetics. It is unclear whether the valve still has a design problem or whether only a few defective valves exist (a manufacturing issue). This safety issue is being addressed by Datex-Ohmeda. For now, it is advisable to monitor carefully for excessive agent concentrations when using the ADU Datex-Ohmeda anesthesia machines, especially if desflurane is administered. 1 carefully designed their study to explore two issues that have not received much attention in the literature: performance of the NICO 2 monitor (Respironics-Novametrix, Wallingford, CT) during low tidal volume controlled ventilation and during spontaneous/mixed ventilation. For low minute volume controlled ventilation, the authors report that the NICO 2 monitor underestimates thermodilution cardiac output and shows decreased precision and accuracy. It is our opinion that the problem was not with the low minute volume. Instead, there are indications that the time allowed for the patients to stabilize following the 50% decrease in minute volume may not have been sufficient.
Taskar et al. 2 showed that the time constant for carbon dioxide output (and end-tidal carbon dioxide) is much longer following a decrease in ventilation than an increase in ventilation. The time constant for a decrease in ventilation was 35 Ϯ 10.7 min after a 10% decrease in ventilation. In other reports, only half of the final change in end-tidal carbon dioxide was realized 16 min after a decrease in ventilation. 3 Changes in end-tidal carbon dioxide and carbon dioxide output are slow because of the time needed for the venous carbon dioxide partial pressure to adjust to the new level needed to allow carbon dioxide excretion to match metabolic carbon dioxide production.
On the basis of these data, it is likely that the venous carbon dioxide levels were still increasing at 15 min after the large decrease in minute volume described by Tachibana et al. 1 This is supported by the authors' report that average carbon dioxide output during the low minute volume mode was still 28% less than in the normal minute volume tests. If we can assume that the patients' metabolic rates did not change with the ventilator adjustment, then the venous carbon dioxide level was not yet stable at the time of measurement. Tachibana et al. noted that the NICO 2 monitor values appeared to be stable during the hypoventilation stage. This does not necessarily imply that the venous carbon dioxide levels were stable, only that they were increasing more slowly. Increasing venous carbon dioxide levels would be expected to cause partial rebreathing cardiac output to read low. This effect would be exacerbated at high cardiac outputs, as the differential end-tidal carbon dioxide signal is smaller.
Also, precision reported for the low minute ventilation test improves considerably (1.27-1.07 l/min), when the single outlier shown in the scatter plot ( fig. 1C of the article) is rejected as an artifact (reducing n from 25 to 24). Moreover, not forcing the regression to pass through the origin improves the correlation significantly, from r ϭ 0.34 to 0.72.
It is our opinion that had the patient remained in hypoventilation until the carbon dioxide output reached its preadjustment level, then the NICO 2 monitor readings would have been as accurate as those observed under normal ventilation. The NICO 2 monitor has been designed to calculate cardiac output after changes in ventilation that are typical in clinical practice. The severe decrease in ventilation tested by Tachibana et al. 1 was outside the typical expected range of change.
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In Reply:-We thank Kück et al. for their response to our study of the NICO 2 monitor, 1 because dialogue between the designers of equipment and those who put it to practical use is valuable. In this case, the clinical implications of our findings do not seem to be apparent to the authors, possibly because of different interpretations of the role of continuous monitoring devices. For the NICO 2 to be of clinical use as a continuous cardiac output (CO) monitor, it should display changes in CO values accurately immediately after minute ventilation (V E ) is decreased. In fact, we found that after 15 min it still underestimates CO. 1, 2 Claiming that the decrease in V E was outside the typical range of change, Kück et al. then suggest that we should wait even longer.
Their case would be strengthened if they could specify appropriate delay periods for different levels of change: for example, how long must we wait for correct readings when V E reduction is less than 20%? Clinicians need to acquire reliable data in real time or, at least, know how to interpret values. If we must wait before getting reliable CO data from the NICO 2 The NICO 2 system uses the following equation:
Here, ⌬VCO 2 is the change in carbon dioxide production between normal breathing and carbon dioxide rebreathing; ⌬Cv CO 2 is the change in venous carbon dioxide content; and ⌬CaCO 2 is the change in arterial carbon dioxide content. If the carbon dioxide dissociation curve is linear, the error caused by baseline drift in Cv CO 2 should mirror the ratio of ⌬Cv CO 2 /⌬CaCO 2 , which is equal to ⌬Pv CO 2 / ⌬PaCO 2 . Because ⌬PaCO 2 during the rebreathing is approximately 2 to 6 mmHg, 4 baseline drift of Pv CO 2 at 0.25 mmHg may be responsible for 4 -13% underestimation, much smaller than the value we observed (30% underestimation). 1 The designers have proposed a new algorithm in which it is unnecessary for Pv CO 2 to reach a constant during carbon dioxide rebreathing CO measurement. 5 We do not know if the system that we evaluated incorporated this revision, but even if it did, something else may be causing the discrepant underestimation. 6 In clinical situations, whether intentional or unintentional, reduction of V E to half is common. Mechanical ventilation at low tidal volume is a standard technique in cases of acute lung injury or adult respiratory distress syndrome. For example, in treating a patient with adult respiratory distress syndrome due to sepsis, during ongoing CO monitoring with NICO 2 , tidal volume would be decreased. In an actual example, Amato et al. reported decreasing tidal volume from 661 ml to 362 ml and observed PaCO 2 to increase from 38.1 mmHg to 58.2 mmHg. 7 In instances of pneumothorax, asthma, pulmonary bleeding, endotracheal tube misplacement, and numerous other clinical situations, V E is likely to suddenly decrease.
Although it seems reasonable to reject a single outlier in scatter plots (figs. 1C and 2C of the article) 1 for linear correlation and bias analysis, the statistical effects of disregarding this point are minor: correlation coefficient, 0.34 to 0.40; slope of linear regression, 0.70 to 0.68; bias, Ϫ1.73 to Ϫ1.88; and precision, 1.27 to 1.07. Ultimately, reducing n from 25 to 24 is useful because it enables us to observe a more consistent underestimation of CO after decreased minute ventilation.
The purpose of our study was to probe the limits of clinical usefulness of the NICO 2 system. We appreciate that because it is noninvasive, easy to use, and works well when V E does not dramatically change, the system generally provides convenient and effective clinical monitoring. Without first evaluating the parameters within which a device provides useful data, however, it would not be prudent, in critical situations, to rely on information from any monitor. Unless clinicians are aware of the limits of the NICO 2 system, blind trust may result in unnecessary use of catecholamines and other less-than-optimal judgment. We thank the designers for providing a piece of equipment that makes it easier for physicians to provide attentive care to patients, and we welcome this opportunity to reiterate that it is crucially relevant for clinicians to be aware that the real-time monitoring accuracy of the NICO 2 system is affected by changes in V E . Although the mathematical model of the cardiovascular system described by the authors seems to be elegant and realistic, the partial rebreathing technique that was analyzed using the model bares little resemblance to what is implemented in the actual commercially available system.
It is incorrect to assume that the algorithm used to calculate pulmonary blood flow in a commercially available system is as simple as what is described in the sales literature. Most modern monitoring devices are based on well-known, yet idealized, equations and derivations of these equations. These equations are only used in actual clinical devices after a series of compensations and corrections have been applied to the raw data. Examples of such devices include thermal dilution cardiac output computers and pulse oximeters. Similarly, currently available partial rebreathing cardiac output computers apply various corrections that compensate for the systematic errors described by Yem et al.
Specifically, Yem et al. describe excessive rebreathing time as a source for underestimation at high cardiac outputs and insufficient rebreathing times as a source of error when cardiac output is low. Yem et al. assume that because the patient rebreathes for 50 s, the partial Fick equation must be applied using the data from the last breath observed during rebreathing. Because data are collected throughout the rebreathing period, the algorithm inside the monitor may select any of the breaths that occur during rebreathing, thereby eliminating the need for variable length rebreathing periods.
The other systematic error source cited by Yem et al. occurs when the rebreathing time is insufficient for equilibrium of the end-tidal carbon dioxide signal to occur. This problem is well documented in the literature related to cardiac output measurement using the total rebreathing method. Various correction techniques dealing with this problem have been described and compared in the literature, 3 and one of these techniques is applied in the NICO 2 system. These and other corrections based on a mathematical model of the lung similar to what Yem et al. have described operate within the NICO 2 partial rebreathing cardiac output system (Novametrix-Respironics, Wallingford, CT). Jaffe 4 and Haryadi et al. 5 describe many of these corrections in two articles; the former is referenced by Yem et In Reply:-We thank Orr et al. for their interest in our article and are pleased to take this opportunity to reply to their comments.
The objective of our article was the analysis of errors that are intrinsic to the standard partial rebreathing technique as reported by Gedeon et al. 1 and others. We did not set out to analyze the performance of any specific instrument. We mentioned the NICO 2 in the introduction of our article 2 because it is one of the more successful instruments commercially available for monitoring pulmonary blood flow using the partial rebreathing method, and because recent studies have questioned its accuracy at both low and high cardiac outputs. [3] [4] [5] We accept that the NICO 2 instrument may use algorithms that are more sophisticated than the standard partial rebreathing equations and that those algorithms do address some of the sources of error we described.
2 Some of the corrections described by Haryadi et al. 6 and Jaffe, 7 however, are intended to compensate for right-to-left shunt and parallel dead-space. In our analysis, 2 our computer model was set up to simulate a healthy lung with negligible shunt and parallel dead-space ventilation, so these corrections were not relevant to our study. We used the same blood gas dissociation curves for calculating carbon dioxide content in our model and partial rebreathing equations, so this potential source of error was also removed.
In their letter, Orr et al. refer to an algorithm that is used to avoid excessive rebreathing times, but there is not enough information in their letter or in the references cited to enable an independent evaluation of the algorithm. They refer to Heigenhauser and Jones, 8 who describe a number of approaches for correcting estimates of quasiequilibrium end-tidal pressure of carbon dioxide when rebreathing times are inadequate, but do not indicate which method is used in the NICO 2 . Haraydi et al. 6 report an algorithm for correcting carbon dioxide output estimates for differences between airway and pulmonary capillary carbon dioxide flux during rebreathing. This algorithm requires knowledge of alveolar volume, which appears to be calculated as a function of the Fowler dead-space, 6 but the relevant equations are not reported or referenced.
We understand that commercial interests might motivate against the publication of some of the intellectual property developed for commercial instruments. However, it is unfortunate that some of the more critical algorithms used in the NICO 2 to improve the partial rebreathing method have not been published in enough detail to allow the independent evaluation suggested by Orr et al. Second, Waters' department, even in its early days, incorporated all the ingredients of current successful academic departments. Teaching and research existed hand in hand with clinical service. The research included work in the laboratory and the operating room. The teaching included frequent departmental meetings. 2 Third, I have been puzzled for years about the reason(s) for the lack of adequate recognition of this pioneer of our specialty. I know that since 1966 a Ralph Waters award and its companion lecture have been presented in a regional anesthesia meeting (The Midwest Anesthesia Conference), and a recent conference was held in Madison, Wisconsin, but are these adequate tributes for the outstanding man of our specialty over the past century? When I started learning anesthesia, I became aware of the name Waters as associated with a "mysterious" (to me) city called Madison, Wisconsin. When I came to Iowa City, Iowa, I made the "pilgrimage" to the city of my hero, which I discovered to be within a few hours' drive. Although a charming university town, I was disappointed by the lack of any tributes I could find to this giant of academic anesthesia and anesthesia in general. I have been told that his reclusiveness after he retired may have contributed to this state of partial neglect. Maybe someone in the future will research his life and his reasons for keeping his distance from the field of anesthesia after his retirement. Perhaps, it was axiomatic that Ralph Waters introduced John Snow, the father of scientific anesthesia, to our specialty in the 1930s. 3 Now is the time to properly introduce Waters, the father of academic anesthesia.
Ralph Milton Waters, M.D.
Finally, the review stated elegantly that Waters' thoughts, observations, and recommendations are as relevant to our specialty currently as they were in his time. I venture to add that they are even more poignant in the current crisis facing academic anesthesia. 
